These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1258 related articles for article (PubMed ID: 24810656)

  • 1. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.
    de Pagter PJ; Schuurman R; Keukens L; Schutten M; Cornelissen JJ; van Baarle D; Fries E; Sanders EA; Minnema MC; van der Holt BR; Meijer E; Boelens JJ
    Bone Marrow Transplant; 2013 Nov; 48(11):1460-4. PubMed ID: 23771003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between human herpesvirus 6 activation and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang LR; Dong LJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):507-10. PubMed ID: 17172120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
    Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
    Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
    Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
    Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
    Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
    J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
    Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
    Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E; Dlubek D; Duda D; Bogunia-Kubik K; Mlynarczewska A; Lange A
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1296-305. PubMed ID: 19747638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.
    Pichereau C; Desseaux K; Janin A; Scieux C; Peffault de Latour R; Xhaard A; Robin M; Ribaud P; Agbalika F; Chevret S; Socié G
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):141-4. PubMed ID: 21801705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
    Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
    Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus types 6 and 7 infection in pediatric hematopoietic stem cell transplant recipients.
    Fule Robles JD; Cheuk DK; Ha SY; Chiang AK; Chan GC
    Ann Transplant; 2014 Jun; 19():269-76. PubMed ID: 24881673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.
    Zerr DM; Corey L; Kim HW; Huang ML; Nguy L; Boeckh M
    Clin Infect Dis; 2005 Apr; 40(7):932-40. PubMed ID: 15824982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
    Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
    PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
    Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
    Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.